Katy Sinka

2.1k total citations
52 papers, 1.1k citations indexed

About

Katy Sinka is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Katy Sinka has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 15 papers in Microbiology and 11 papers in Infectious Diseases. Recurrent topics in Katy Sinka's work include Reproductive tract infections research (14 papers), HIV, Drug Use, Sexual Risk (13 papers) and Syphilis Diagnosis and Treatment (9 papers). Katy Sinka is often cited by papers focused on Reproductive tract infections research (14 papers), HIV, Drug Use, Sexual Risk (13 papers) and Syphilis Diagnosis and Treatment (9 papers). Katy Sinka collaborates with scholars based in United Kingdom, France and United States. Katy Sinka's co-authors include Barry Evans, Caroline Sabin, T Chadborn, Valérie Delpech, Martin Donaghy, Kate Soldan, B.G. Evans, A Potts, Kimberley Kavanagh and Dilys Morgan and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Katy Sinka

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katy Sinka United Kingdom 18 737 502 214 183 141 52 1.1k
Andrew J. Amato‐Gauci Sweden 24 837 1.1× 673 1.3× 292 1.4× 91 0.5× 152 1.1× 51 1.4k
Matthew M. Hamill United States 16 656 0.9× 412 0.8× 247 1.2× 99 0.5× 109 0.8× 82 1.3k
Amy Matser Netherlands 19 626 0.8× 935 1.9× 148 0.7× 82 0.4× 98 0.7× 62 1.4k
Daniel Richardson United Kingdom 18 562 0.8× 394 0.8× 264 1.2× 60 0.3× 74 0.5× 112 1.1k
Titia Heijman Netherlands 19 750 1.0× 547 1.1× 326 1.5× 85 0.5× 91 0.6× 67 1.2k
Dora Warren United States 12 415 0.6× 359 0.7× 189 0.9× 97 0.5× 117 0.8× 17 856
Sinéad Delany South Africa 15 412 0.6× 451 0.9× 360 1.7× 133 0.7× 106 0.8× 20 891
Jenell S. Coleman United States 22 568 0.8× 374 0.7× 516 2.4× 77 0.4× 325 2.3× 79 1.5k
Muhammad S. Jamil Switzerland 17 636 0.9× 668 1.3× 251 1.2× 254 1.4× 96 0.7× 78 1.1k
Mary K. Sawyer United States 17 474 0.6× 226 0.5× 282 1.3× 183 1.0× 72 0.5× 26 1.0k

Countries citing papers authored by Katy Sinka

Since Specialization
Citations

This map shows the geographic impact of Katy Sinka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katy Sinka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katy Sinka more than expected).

Fields of papers citing papers by Katy Sinka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katy Sinka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katy Sinka. The network helps show where Katy Sinka may publish in the future.

Co-authorship network of co-authors of Katy Sinka

This figure shows the co-authorship network connecting the top 25 collaborators of Katy Sinka. A scholar is included among the top collaborators of Katy Sinka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katy Sinka. Katy Sinka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pitt, Rachel, Stephen Hughes, Hugo Donaldson, et al.. (2024). Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016–20. Journal of Antimicrobial Chemotherapy. 79(5). 1060–1068. 2 indexed citations
3.
Charles, Hannah, Katy Sinka, Ian Simms, et al.. (2024). Trends in shigellosis notifications in England, January 2016 to March 2023. Epidemiology and Infection. 152. e115–e115. 4 indexed citations
4.
Witzel, T. Charles, Romain Palich, Hannah Charles, et al.. (2024). Experiences of mpox illness and case management among cis and trans gay, bisexual and other men who have sex with men in England: a qualitative study. EClinicalMedicine. 70. 102522–102522. 17 indexed citations
5.
Ladhani, Shamez, Peter J White, Helen Campbell, et al.. (2024). Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK. The Lancet Infectious Diseases. 24(9). e576–e583. 20 indexed citations
6.
Talebi, Alireza, et al.. (2023). STI testing, diagnoses and online chlamydia self-sampling among young people during the first year of the COVID-19 pandemic in England. International Journal of STD & AIDS. 34(12). 841–853. 4 indexed citations
7.
8.
Charles, Hannah, Kirsty Foster, Richard Ma, et al.. (2023). Spotlight on drug-resistantShigella: raising awareness within general practice. British Journal of General Practice. 73(729). 187–188. 2 indexed citations
9.
10.
Beale, Mathew A., Michelle Cole, Rachel Pitt, et al.. (2023). Genomic epidemiology of syphilis in England: a population-based study. The Lancet Microbe. 4(10). e770–e780. 16 indexed citations
11.
Allen, Hester, Rachel Pitt, Hamish Mohammed, et al.. (2022). Is there an association between previous infection withNeisseria gonorrhoeaeand gonococcal AMR? A cross-sectional analysis of national and sentinel surveillance data in England, 2015–2019. Sexually Transmitted Infections. 99(1). 1–6. 9 indexed citations
12.
Cole, Michelle, Rachel Pitt, Michaela Day, et al.. (2022). Antimicrobial-resistant gonorrhoea: the national public health response, England, 2013 to 2020. Eurosurveillance. 27(40). 22 indexed citations
13.
Bardsley, Megan, Ellen Heinsbroek, Ross Harris, et al.. (2021). The impact of direct‐acting antivirals on hepatitis C viraemia among people who inject drugs in England; real‐world data 2011–2018. Journal of Viral Hepatitis. 28(10). 1452–1463. 11 indexed citations
14.
Fifer, Helen, Rachel Pitt, Hester Allen, et al.. (2021). Frequency and Correlates of Mycoplasma genitalium Antimicrobial Resistance Mutations and Their Association With Treatment Outcomes: Findings From a National Sentinel Surveillance Pilot in England. Sexually Transmitted Diseases. 48(12). 951–954. 10 indexed citations
15.
Gill, O Nöel, Y. I. Spencer, Angela Richard-Loendt, et al.. (2020). Prevalence in Britain of abnormal prion protein in human appendices before and after exposure to the cattle BSE epizootic. Acta Neuropathologica. 139(6). 965–976. 23 indexed citations
16.
Harris, Magdalena, Vivian Hope, Talen Wright, et al.. (2020). Factors associated with skin and soft tissue infections among people who inject drugs in the United Kingdom: A comparative examination of data from two surveys. Drug and Alcohol Dependence. 213. 108080–108080. 23 indexed citations
17.
Kavanagh, Kimberley, Katy Sinka, Kate Cuschieri, et al.. (2013). Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact. BMC Infectious Diseases. 13(1). 519–519. 26 indexed citations
18.
Kavanagh, Kimberley, et al.. (2013). Effect of HPV Assay Choice on Perceived Prevalence in a Population-based Sample. Diagnostic Molecular Pathology. 22(2). 85–90. 17 indexed citations
19.
Chadborn, T, Valérie Delpech, Caroline Sabin, Katy Sinka, & Barry Evans. (2006). The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004). AIDS. 20(18). 2371–2379. 192 indexed citations
20.
Soldan, Kate & Katy Sinka. (2003). Evaluation of the de‐selection of men who have had sex with men from blood donation in England. Vox Sanguinis. 84(4). 265–273. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew J. Amato‐Gauci Breakdown of academic impact, for papers by Matthew M. Hamill Breakdown of academic impact, for papers by Amy Matser Breakdown of academic impact, for papers by Daniel Richardson Breakdown of academic impact, for papers by Titia Heijman Breakdown of academic impact, for papers by Dora Warren Breakdown of academic impact, for papers by Sinéad Delany Breakdown of academic impact, for papers by Jenell S. Coleman Breakdown of academic impact, for papers by Muhammad S. Jamil Breakdown of academic impact, for papers by Mary K. Sawyer
Rankless by CCL
2026